Seabuck Ayurveda Profile
Key Indicators
- Authorised Capital ₹ 0.30 M
as on 24-06-2024
- Paid Up Capital ₹ 0.20 M
as on 24-06-2024
- Company Age 16 Year, 6 Months
- Last Filing with ROC 31 Mar 2018
- Open Charges ₹ 6.00 M
as on 24-06-2024
- Revenue 43.00%
(FY 2018)
- Profit -17.34%
(FY 2018)
- Ebitda -506.35%
(FY 2018)
- Net Worth 1.26%
(FY 2018)
- Total Assets 140.41%
(FY 2018)
About Seabuck Ayurveda
The Corporate was formerly known as Sara Cosmetics Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2018. It's a company limited by shares with an authorized capital of Rs 0.30 M and a paid-up capital of Rs 0.20 M.
The company currently has active open charges totaling ₹6.00 M.
Meenal Modi and Vishal Modi serve as directors at the Company.
- CIN/LLPIN
U74120DL2008PTC179593
- Company No.
179593
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Jun 2008
- Date of AGM
29 Sep 2018
- Date of Balance Sheet
31 Mar 2018
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
South Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Seabuck Ayurveda Private Limited offer?
Seabuck Ayurveda Private Limited offers a wide range of products and services, including Cosmetics, Hair & Beauty Products, Body Cream, Body Scrubs, Skin Care Cosmetics, Hair Care Cosmetics, Hand Sanitizers & Personal Hygiene, Beauty Soap, Bleaching Cream, Facial Kit, Face Wash.
Who are the key members and board of directors at Seabuck Ayurveda?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Meenal Modi  | Director | 16-Jun-2008 | Current |
| Vishal Modi | Director | 16-Jun-2008 | Current |
Financial Performance of Seabuck Ayurveda.
Seabuck Ayurveda Private Limited, for the financial year ended 2018, experienced significant growth in revenue, with a 43% increase. The company also saw a substantial fall in profitability, with a 17.34% decrease in profit. The company's net worth moved up by a moderate rise of 1.26%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Seabuck Ayurveda?
In 2018, Seabuck Ayurveda had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 03 Mar 2017 | ₹6.00 M | Open |
How Many Employees Work at Seabuck Ayurveda?
Unlock and access historical data on people associated with Seabuck Ayurveda, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Seabuck Ayurveda, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Seabuck Ayurveda's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
